Despite the rise of new imaging techniques, such as prostate-specific membrane antigen (PSMA) PET/CT [4,5], extended lymph node dissection (eLND) remains the gold standard for LN staging in clinically localized prostate cancer [6]. Here, FOLH1 is linked to prostate cancer.